The species human parvovirus B19 (B19V) can be divided into three genotypes. In this study, we addressed the question as to whether infection of an individual is restricted to one genotype. As viral DNA is detectable in tissue for long times after acute infection, we examined 87 liver specimens from adults for the presence of B19V DNA. Fifty-nine samples were found to be positive, 32 of them for genotype 1, 27 for genotype 2 and four for genotype 3. In four samples, DNA of two genotypes was detected; samples from three individuals were positive for genotypes 1 and 2 and a sample from one individual was positive for genotypes 1 and 3. Surprisingly, significant sequence heterogeneity was observed at approximately 1 % of the nucleotides of the genotype 1 genomes from individuals with double genotype 1 and 2 infection. Controls using different enzymes for genome amplification and dilutions of the template verified that nucleotide heterogeneity was due to the presence of three or more genome variants of genotype 1. In summary, the evidence shows that individuals can be infected with two different genotypes, and B19V DNA can persist as a population of different genomes. The results may have implications for the understanding of the antiviral immune response and the development of vaccines against B19V.
INTRODUCTION
Human parvovirus B19 (B19V), a small non-enveloped virus, is a common pathogen typically causing a mild febrile illness with a rash during childhood (Anderson et al., 1983) . In adults, infection often manifests as symmetrical arthropathy, which may persist (Woolf et al., 1989) . Due to viral replication in the erythroid progenitor cells, severe or lifethreatening diseases can occur in immunocompromised patients and in individuals with shortened red cell survival (Brown et al., 1984; Kurtzman et al., 1988; Pattison et al., 1981; Public Health Laboratory Service, 1990; Skjöldebrand-Sparre et al., 2000) . Besides the typical features, B19V is implicated in a wide spectrum of illnesses including neurological, cardiac, hepatic and rheumatological disorders (Broliden et al., 2006; Kerr et al., 2002; Lehmann et al., 2003; Young & Brown, 2004) .
The B19V genome consists of a single-stranded DNA, approximately 5.6 kb in length that encodes three large proteins (Clewley, 1984; Cotmore et al., 1986; Deiss et al., 1990) . The non-structural protein NS1 is composed of 671 aa, the capsid proteins VP1 and VP2 are composed of 781 and 554 aa, respectively. Since the reading frames of VP1 and VP2 are in-frame, the two proteins are identical except for the additional unique portion of VP1 (VP1u) at its amino-terminal end (Ozawa et al., 1987) .
Until recently, genotype 2 viraemic individuals were found relatively infrequently (Blümel et al., 2005; Cohen et al., 2006; Liefeldt et al., 2005; Nguyen et al., 1998 Nguyen et al., , 1999 Nguyen et al., , 2002 Servant et al., 2002) . Even in plasma factor concentrates, produced from thousands of blood donations, genotype 2 DNA was only detected in a very small percentage of individuals (Schneider et al., 2004) . In contrast, genotype 2 DNA was found at a much higher frequency in tissue from individuals older than approximately 40 years of age, leading to the assumption that genotype 2 has widely disappeared from circulation (Norja et al., 2006) . Genotype 3 virus was shown to be endemic in Ghana, West Africa (Candotti et al., 2004) and may be present in a certain region of Brazil (Sanabani et al., 2006) . Outside these areas, only a few sporadic cases of viraemic infection have been reported in France (Nguyen et al., 1998 (Nguyen et al., , 1999 Servant et al., 2002) and one case was identified in the UK (Cohen et al., 2006) . In an investigation performed in the USA, even the persisting genotype 3 DNA has only been found in a small percentage of tissue samples (Wong et al., 2003) .
One of the main questions raised by the discovery of the new viral variants is whether the similarity between the genotypes results in restriction of infection to one genotype or whether multiple infections are possible. To answer this question, we examined liver tissue samples from adults for the presence of B19V DNA of genotypes 1, 2 and 3. The liver tissue was chosen because it harbours persisting DNA at a high frequency (Eis-Hübinger et al., 2001; Norja et al., 2006) . The results presented here show that a small proportion of B19V-infected livers contains DNA of two genotypes, indicating double infection. In double-infected specimens of genotypes 1 and 2, a repertoire of genotype 1 genome variants was detected.
METHODS
Specimens. A total of 87 samples of liver tissue was investigated. Sixty-three specimens were from the patient's own liver removed during liver transplantation, three were from the transplanted liver, five from non-transplanted liver patients and 16 specimens from autopsied individuals. From six autopsied individuals, bone marrow specimens were additionally investigated. Adequate sera, obtained before tissue collection, were available from 71 individuals. None of the individuals had received blood or blood products during the last 6 months. All specimens were obtained for diagnostic purposes.
B19V serological assays. Anti-B19V IgG and IgM antibodies were measured in sera using an ELISA based on baculovirus-expressed VP2 (Biotrin).
PCR for screening. DNA was prepared by spin-column procedure as described previously (Eis-Hübinger et al., 2001) . Nested PCR for the detection of genotype 1 DNA was performed as described earlier (Eis-Hübinger et al., 2001) . Nested PCR for the detection of genotype 2 DNA was carried out as described elsewhere (Schneider et al., 2004) . Primers for the amplification of genotype 3 DNA were as follows (59-39, positions according to GenBank accession no. AX003421): outer forward, nt 2235-2254; outer reverse, nt 2511-2488; inner forward, nt 2260-2279; inner reverse, nt 2374-2355. PCR conditions were identical to genotype 2 PCR except for annealing at 55 uC. Positive and negative controls were included in every run. Strict precautions to avoid contamination were taken. The sensitivity of the PCRs was less than two genome equivalents per reaction. Since especially the specificity of the genotype 1 PCR against genotype 3 virus was limited, genotyping of all viruses was performed by extended DNA sequence analysis. The results of the screening PCR for genotypes 1 and 2 from 81 and 77 liver samples, respectively, and for genotype 1 from the six bone marrow specimens have been reported (EisHübinger et al., 2001; Norja et al., 2006) . DNA sequence analysis. Nucleotide sequence analysis of the viral genomes was performed by direct sequencing of amplicons generated by nested PCR. Amplification of genotype 1 genome fragments was done with the primer sets NS1-C, DV and VP1/VP2 (Hemauer et al., 1996) , DV-III G1 and VPint G1 (Schneider et al., 2004) , and the primer sets given in Supplementary Table S1 (available in JGV Online). Amplification of genotype 2 DNA was performed with the primer sets NS1-C G2 , DV G2 , VP1/VP2 G2 , VPint G2 , VPC G2 and VPext G2 (Schneider et al., 2004) , and the primer sets shown in Supplementary Table S3 (available in JGV Online). Primer sets for genotype 3 are given in Supplementary Table S4 (available in JGV Online). Unless otherwise indicated, PCR was performed by using the Expand High Fidelity PCR system (Roche; enzyme A). Additional enzymes used were Easy-A High-Fidelity PCR Cloning Enzyme (Stratagene; enzyme B), BD Advantage-HF 2 kit (BD Biosciences Clontech; enzyme C) and PfuUltra High-Fidelity DNA Polymerase (Stratagene; enzyme D).
Nested PCR products were purified by QIAquick PCR Purification kit (Qiagen) and sequencing reactions were carried out using approximately 5-20 ng of the purified product. If not otherwise indicated, amplicons from at least two independent PCR reactions were sequenced in the forward and reverse directions using the nested primers. Sequencing was performed with the ABI Prism BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems).
Reactions were run on an ABI Prism 3130 (Applied Biosystems). Sequencing data were reviewed manually. Alignments were generated by CLUSTAL_X version 1.81 and sequence editing was performed using BioEdit (v7.0.5). In the case of double-infected samples, the sequence of each amplicon was individually aligned. DNA distance matrices were generated by using BioEdit. Phylogenetic trees were constructed by the neighbour-joining method (Saitou & Nei, 1987) . To confirm the reliability of the phylogenetic trees, bootstrap resampling tests were performed 1000 times (Felsenstein, 1981) . Visualization of the phylogenetic tree was performed using TreeView (version 1.4; http:// taxonomy.zoology.gla.ac.uk/rod/treeview.html).
For detailed analysis of genome 31.1, the nucleic acid preparation was serially twofold diluted in sterile pharmacy water down to 1 : 1024 and dilutions subjected in triplicate to PCR using the primer set DV-III G1 . Additionally, the nucleic acid preparation was diluted 1 : 5 and subjected to PCR in quadruplicate.
Cloning of PCR products and mixing experiments. Genotype 1 PCR products were generated from plasmid pGEM-1/B19 using the outer primers DV-III G1 . The plasmid was kindly provided by Dr Jonathan P. Clewley, Central Public Health Laboratory, London, UK. Genotype 2 PCR products were generated from genotype 2 virus IM-81 (Blümel et al., 2005) ) and subjected to nested PCR using primer set DV-III G1 . Except for a template volume of 2 ml in the first round, PCR was performed as described previously (Schneider et al., 2004) . After purification, the inner product was sequenced. The PCR reliably detected 2.5 genotype 1 genome equivalents per reaction. Genotype 2 DNA was amplified when present as the sole genotype in the reaction in a concentration of approximately ¢4610 4 genome equivalents per reaction as determined by plasmid titration.
RESULTS
Detection of more than one B19V genotype in single individuals A total of 87 liver specimens was investigated by screening PCRs for genotypes 1, 2 and 3 DNA, respectively, followed by verification of the positive results by direct nucleotide analysis of a large B19V genome region (Fig. 1) . The sequenced region of genotypes 1 and 2 DNA spanned from nt 1895 to 3064 (numbering according to genotype 1 prototype strain Au); sequencing was performed by using the primer sets NS1-C G1 and DV G1 /DV-III G1 (the latter one for two specimens for which no amplicons could be generated by DV) and the primer sets NS1-C G2 and DV G2 , respectively. Genotype 3 genomes were sequenced from nt 36 to 4967 (numbering according to genotype 3 subtype D91.1) with the primer sets given in Supplementary Table  S4 (available in JGV Online).
Overall, genotypes 1, 2 and 3 DNA was detected in 32, 27 and four specimens, respectively. All sequences were either typical genotype 1, 2 or 3 sequences (Fig. 2) . Four of the infected specimens showed double infection. In three specimens, double infection with genotypes 1 and 2 was detected, in one specimen double infection with genotypes 1 and 3 was detected. At least one genotype was present in 59 of 87 (67.8 %) specimens.
Genetic diversity within the B19V genotypes
Direct sequence analysis of the genotype 1 genomes derived from the genotypes 1 and 2 co-infected specimens (sequences 31.1, 32.1, 33.1 from specimens 31, 32, 33, respectively) reproducibly revealed nucleotide heterogeneity at single positions. To verify this result, direct sequence analysis of the three genomes was extended to nt (Au) 158-5047 representing 87 % of the B19V genome. At least four independently amplified PCR products of each target region were sequenced in both directions using the primer sets given in Supplementary Table S2 (available in JGV Online).
Extended sequence analysis also reproducibly revealed heterogeneities at single nucleotide positions, i.e. ambiguities (simultaneous detection of different nucleotides as double peaks in the chromatogram) as well as separate detection of each nucleotide observed at that position. The heterogeneities were observed at the same positions in different sequence reactions performed on independently generated PCR amplicons. The total number of polymorphic positions in genomes 31.1, 32.1 and 33.1 was 49, 63 and 64, respectively (1.00-1.31 % of the nucleotides). The polymorphisms were scattered throughout the whole of the sequences. Except for one position in genome 32.1 and one position in genome 33.1, the polymorphisms were M13178). For genotype 3 genomes, the nucleotide numbering is according to genotype 3 subtype D91.1 (GenBank accession no. AY083234), and for better comparison, the numbering according to Au is given in parentheses. The genome fragments amplified by the screening PCRs are given including the inner primers, the sequenced genome regions are given without the primers. For genomes sequenced over approximately 1 kb, the primer sets used are given above the bars. For the largely sequenced genomes, the primers sets used are given in Supplementary Tables S2-S4 (available (Table 1) .
Overall, the nucleotide polymorphisms were identified at a total of 105 genomic positions. Notably, at 26 and 21 of these positions the type of heterogeneity was identical in two and three genomes, respectively. Additionally, at position 1392, heterogeneity (C/A) was identical in two genomes, while the third genome displayed three bases (A/ T/C) including the two bases detected in the other DNA isolates. Similarly, at position 924 one genome displayed C/ T, while another one displayed A/T/C. Thus, 47 % (49/105) of the polymorphic positions were identical in at least two genomes. Furthermore, in nearly all of these positions the type of heterogeneity was identical.
By comparison with prototype strain Au and the 25 longest genotype 1 genome sequences available in the database (strains Vn115 and Vn147 not considered), we analysed whether the heterogeneities were at positions where genotype 1 displays a high degree of divergence (Table 1) . Alignment showed that at 67 of 105 (63.8 %) polymorphic positions all comparison strains had an identical nucleotide. Interestingly, at 23 of 67 (34.3 %) positions two or all three polymorphic isolates displayed the same sequence polymorphism.
The most frequent polymorphism observed was A/G (43 positions), the second frequent polymorphism was C/T (38 positions). A/G was present at positions where the comparison strains displayed A or G except for two positions where the majority of comparison strains displayed G but a minority showed T. C/T was present at Fig. 2 . A phylogenetic tree constructed by the neighbour-joining method based on the genomic region between nt 1940 and 3020 (positions according to genotype 1 prototype strain Au, GenBank accession no. M13178). The DNA isolates presented in this study are numbered consecutively and are compared with the prototype strains for genotypes 1, 2 and 3, given in bold (GenBank accession nos: Wi, M24682; LaLi, AY044266; A6, AY064475; V9, AX003421; and D91.1, AY083234). For the calculation of the divergence of sequences 31.1, 32.1 and 33.1, the sequence with maximum divergence to genotype 1 prototype strain Au was used. The sequenced region spanned nt (Au) 158-5047. Shown are all positions that differ from genotype 1 prototype strain Au (GenBank accession no. M13178). For further comparison, the nucleotides at the respective positions of 25 long sequenced genotype 1 genomes available in the database are given. The GenBank accession numbers of these sequences are AY386330 (J35), AF162273 (HV), AY504945 (NAN), M24682 (Wi), Z68146 (Stu), AB030693 (Mi), AB030694 (Rm), AB030673 (N8), AB126262 (AN23), DQ225149 (SN807), DQ225148 (KyMa), DQ225151 (AnTo), DQ225150 (OsFr), DQ293995 (C39), Z70560 (I/1), Z70528 (2/II), AF113323, AJ781031 (1), AJ781032 (2), AJ781033 (3), AJ781034 (4), AJ781035 (5), AJ781036 (6), AJ781037 (7) and AJ781038 (8). n, Number of sequences available at the indicated position. Deduced amino acid exchanges refer to those nucleotides that differ from the nucleotides of prototype strain Au. Nucleotide heterogeneities are indicated in bold. Persistence of genomic variants of human parvovirus B19 positions represented by T or C in the comparison strains except for one position where one comparison strain displayed G.
Only a small proportion of the polymorphisms in genomes 31.1 and 33.1 resulted in changes of the deduced amino acids of the large viral proteins. The ratio of nonsynonymous to synonymous changes was 0.0625 (genome 31.1) and 0.1667 (genome 33.1) for the non-structural protein NS1, and 0.0870 and 0.0313 for the minor capsid protein VP1, respectively. Although the proportion of polymorphisms in the VP2-coding sequence was not significantly lower than in NS1-and VP1u-coding sequences, no changes would occur in VP2. In genome 32.1, the proportion of non-synonymous substitutions resulting from nucleotide polymorphism was higher and changes in the deduced amino acid sequences were present in each protein (ratio 0.3500, 0.3000 and 0.1875 for NS1, VP1 and VP2, respectively).
By direct sequencing the genotype 1 sequence derived from the genotypes 1 and 3 co-infected specimen (sequence 30.1) no polymorphism was observed. At least three independent PCR and sequencing reactions of each target region were performed using the primers sets given in Supplementary Sequence analysis showed that genotype 2 genome 32.2 displayed greater divergence to the respective prototype strains than the other genotype 2 genomes (distance matrices to strains LaLi and A6, 0.0396 and 0.0443, respectively). Alignment of the genotype 3 sequences with the respective prototype strains showed that all four genomes were more closely related to subtype D91.1 than to subtype V9. Interestingly, at the deduced amino acid level of the structural proteins VP1 and VP2, the DNA isolates were, however, more closely related to V9. Among the large B19V proteins NS1, VP1 and VP2, the genomic divergence to V9 and D91.1 was highest in the sequence encoding the main viral capsid protein VP2; however, was lowest at the deduced amino acid level.
Genetic diversity among the genotypes within a patient
Nucleotide sequence divergence (distance matrix) between the genotypes within an individual were 0.1453 (genotype 1 vs genotype 3), and 0.1323, 0.1249 and 0.1172 (genotype 1 vs genotype 2). Thus, the divergency rates were in the typical range of discrepancy between B19V genotypes. For the genotype 1 sequences, minimum genetic distance was calculated because of the ambiguities.
In the region between nt (Au) 309 and 4830, the sequences of all three pairs of genotype 1 and 2 viruses were available. Table 1 . cont.
B. Schneider and others
The number of nucleotides differing between the genotypes within a pair was 544, 529 and 537, respectively. Genotype 1 heterogeneities were observed at 47, 55 and 60 positions, respectively. The majority of heterogeneities (60, 55 and 57 %) were located at positions where the reference strains Au and LaLi as well as the genotype 2 genome originating from the same specimen exhibited the same nucleotide. The genotype 1 and 2 reference strains differed by 511 positions. Thus, it seemed unlikely that the polymorphisms observed in the genotype 1 sequences were due to coamplification of genotype 2 DNA. This assumption is supported by the fact that in all three genotype 1 genomes an ambiguity was observed in the promoter region between nt (Au) 310 and 314. In all three genotype 2 genomes the corresponding positions were deleted.
Analysis of sequence variation
To verify the phenomenon of sequence polymorphism, genome 31.1 was amplified by primer set DV-III G1 using three additional enzymes (B, C and D) followed by direct nucleotide sequence analysis. With enzymes B and C four independent PCR and sequencing reactions, for each enzyme, were performed (B1-B4 and C1-C4). With enzyme D an amplicon was obtained only in one reaction (D1). With the enzyme used so far (A), eight independent reactions (A1-A8) were carried out. Clearly readable sequences were obtained in all reactions between nt (Au) 2247 and 3284.
Using enzyme A, nucleotide polymorphisms were observed at 13 positions (Fig. 3) . Using the enzymes B and C, polymorphism was observed at the same positions, though not as ambiguities, i.e. as double peaks in the chromatogram. Thus, the results indicated that the polymorphism observed in the genotype 1 genomes was unlikely to be due to inaccuracy of enzyme A used so far. Four types of unambiguous genotype 1 sequences could be differentiated: type I, sequences A4-A6, B2-B4, C2-C4 and D1; type II, sequences A1 and A2; type III, sequence B1; type IV, sequence C1. Except for the 13 polymorphic positions, all other positions differing between genotype 1 and 2 from specimen 31 showed identical nucleotides, irrespective of the enzyme used. Fig. 3 shows the results for all positions (n572) where the reference strains Au and LaLi and the genomes 31.1 and 31.2 were not homologous to each other.
For further verification of sequence polymorphism, dilutions of the DNA preparation of specimen 31 were subjected to PCR with primer set DV-III
G1
. Amplicons were yielded in one out of three reactions performed on the dilutions 1 : 2, 1 : 4 and 1 : 32, respectively, and one out of four reactions performed on the dilution 1 : 5. Nucleotide analysis of the amplicons revealed three of the four known sequence types without ambiguities (Table 2 ). This observation supports the hypothesis that three or more variants of genotype 1 genomes are present in the same tissue.
To exclude the possibility that the detected polymorphism of genotype 1 sequences was an artificial consequence of the presence of genotype 2 DNA in the same specimen, experiments with mixtures of cloned genotype 1 and 2 DNAs were performed. Homologous genome regions were amplified from plasmid pGEM-1/B19 and from genotype 2 virus IM-81 using the outer primers of primer set DV-III G1 and primers DV-III
G2
, respectively. Equal volumes of serially 10-fold diluted plasmid pDV-III G1 (approx. 3.2610 9 -3.2 copies) and constant amounts of plasmid pDV-III G2 (approx. 3.2610 9 copies) were mixed and subjected to first and second round PCR using the primer set DV-III G1 followed by sequencing. -3.2 copies) double peaks were seen in the chromatogram at all positions the two genotypes differed from each other. Thus, the experiments showed that the pattern of nucleotide polymorphism due to co-amplification of genotype 2 is different from that observed in the polymorphic genotype 1 genomes, revealing the majority of polymorphisms at positions identical between the genotypes. Furthermore, the results showed that the polymorphic genotype 1 sequences presented fewer ambiguities than would be expected from co-amplification of two genotypes.
In summary, the results showed that three or more genotype 1 genome variants were present in the same tissue.
Relationship between B19V DNA detection and antibody status
Adequate sera were available from 71 individuals. Fiftynine sera were B19V IgG-positive. B19V DNA, irrespective of its genotype, was present in 45 (76.3 %) liver specimens from seropositives. The detailed detection rates for genotypes 1, 2 and 3 DNA were 39.0, 37.3 and 3.4 %, respectively. Except for one specimen containing genotype 2 DNA, no B19V DNA was found in the samples from the 12 seronegatives. All sera tested negative for B19V IgM.
Identical B19V genome sequences at various body sites
Bone marrow specimens from six individuals were tested by PCR for genotypes 1, 2 and 3 DNA followed by sequence analysis (Table 3 ). In two individuals already found to host genotype 2 DNA in the livers, genotype 2 DNA was also detected in the bone marrow. Viral sequences within one individual were identical. One of these individuals was B19V-seronegative as described above. Identity of the B19V DNA at different body sites Fig. 3 . Sequence analysis of the polymorphic genotype 1 genome 31.1 after amplification with four different enzymes. With enzymes A, B, C and D eight (A1-A8), four (B1-B4 and C1-C4) and one (D1) independent PCR and sequencing reactions were performed, respectively. The sequenced region spanned nt (Au) 2247-3284. Given are all nucleotides that are not identical between the 31.1 sequence, genotype 1 reference strain Au (GenBank accession no. M13178), genotype 2 reference strain LaLi (GenBank accession no. AY044266) and genotype 2 genome 31.2 at the corresponding positions. Sequences are listed according to their similarity. Nucleotides that differ between the reference strains Au and LaLi are highlighted in yellow and blue, respectively. Nucleotides in the genomes 31.1 and 31.2 are coloured accordingly. Dark green background indicates nucleotides that are identical between the reference strains and the genomes 31.1 or 31.2. Light green background indicates nucleotides that differ from the nucleotides depicted in dark green. Ambiguities are shown as colourless.
was further observed in an individual with genotype 1 persistence. Sequencing was done from nt (Au) 1912 to 3023 using the primer sets NS1-C and DV or NS1-C G2 and DV
G2
, respectively.
DISCUSSION
Long-term persistence of B19V DNA in human tissue is a well known feature (Cassinotti et al., 1997; Eis-Hübinger et al., 2001; Söderlund et al., 1997; Wong et al., 2003) . After acute infection, residual viral DNA can remain in tissue for decades or even lifelong ('bioportfolio') (Norja et al., 2006) . Herein, we report on the co-persistence of different genotypes and several genomic variants belonging to the same genotype.
Of the 59 specimens hosting B19V DNA of either genotype, simultaneous persistence of two genotypes was detected in four (7 %) samples. Although the number of cases with double B19V infection is limited, the question is pertinent as to how infection with two genotypes can occur. At present, we can only speculate about possible explanations. The favoured hypothesis is that infections were acquired sequentially (superinfection). However, this would implicate that, at least in a certain percentage of individuals, infection with one genotype does not confer sufficient protective immunity against infection with another genotype. Since especially neutralizing antibodies are essential for clearance of acute infection and confer lasting protection (Anderson et al., 1985; Kurtzman et al., 1989) , a weaker than usual neutralizing antibody response might be a reason why superinfection can occur. In a study by Blümel et al., 2005, genotype 2 virus was cross-neutralized in vitro by sera from patients having recovered from acute genotype 1 infection. However, in sera from some patients, neutralizing activity was somewhat lower for the heterologous genotype. Concerning the route of infection, transmission of B19V via respiratory secretions is the most common way. Concerning the fact that double infection was detected in four of 59 specimens positive for B19V DNA, this way of transmission seems most obvious to us. Alternatively, transmission of the second virus might have occurred via blood transfusion circumventing the natural barrier for entry. Recently, a case of short, low-level viraemia after exposure to a contaminated blood cell preparation in an already seropositive leukaemia patient was described, indicating that superinfection is possible in principle although rare . Though not very likely, the possibility of concomitant infection with two genotypes cannot be completely ruled out.
Sequence analysis revealed nucleotide polymorphism in three genotype 1 genomes. Cloning of amplicons used for direct sequence analysis into the pCR4-TOPO plasmid followed by sequence analysis of individual clones confirmed the sequence variants. Cloning of the PCR product A5, which displayed an unambiguous sequence, by direct sequencing (Fig. 3) , resulted in all clones displaying the same nucleotides as were observed by direct sequencing at the positions with polymorphisms. Furthermore, the sequence obtained by direct sequencing was identified in a clone. Similarly, cloning of amplicon B3, which also displayed by direct sequence analysis an unambiguous 
*Shown are positions that differ from genotype 1 prototype strain Au. Persistence of genomic variants of human parvovirus B19
sequence that was identical to the sequence A5 (sequence type I), resulted in all clones showing the same nucleotides as those found by direct sequencing. In contrast, cloning of PCR product A7, displaying ambiguities by the direct sequencing approach, resulted in clones which showed either one or the other version of bases at the respective positions. One of four clones sequenced revealed sequence type IV, thus was identical to sequence C1 obtained by direct sequencing using another enzyme (enzyme C). Cloning of PCR reaction A3, which also displayed ambiguities, resulted in a clone that displayed one alternative of the ambiguities. This cloned sequence was identical to the sequences A1 and A2 obtained by direct sequencing (sequence type II).
Comparison with genotype 1 DNA sequences available in the database showed that the heterogeneities were not at positions displaying a high degree of nucleotide divergence. Surprisingly, a substantial proportion of polymorphisms was present at identical positions in two or three genomes and, additionally, displayed the same type of heterogeneity. This phenomenon and the fact that the pattern of nucleotide segregation was reproducibly observed at the same positions suggest that the polymorphism is more likely to represent a heterogeneous population of genotype 1 DNA molecules belonging to the same viral genotype than artefacts. However, the finding that polymorphism was not seen in specimens other than those doubly infected by genotypes 1 and 2 does not imply the strict absence of polymorphism in singly infected specimens since a critical amount of the variant sequence is necessary for being detectable by direct sequencing. Furthermore, we are aware that possibly not all variants may be recognized by the direct sequence analysis.
The mechanism by which persistence of several variants of genomes belonging to the same genotype is accomplished is currently unknown. Analogous to simultaneous persistence of two genotypes, reinfection might occur. However, since there was evidence for co-persistence of three or more variants, repeated reinfection has to be assumed. Another explanation could be that the genetic diversity has evolved during the acute infection. Especially during the initial phase of B19V infection, characterized by high levels of viral replication, there might be a greater chance of appearance of inaccurately replicated B19V DNA; although, the viral DNA is replicated by the host cell machinery. It has been recently speculated by others (Ló pez-Bueno et al., 2003; Shackelton & Holmes, 2006) that the fidelity and the proofreading activity of the enzymic complex containing the host DNA polymerase, recruited cellular replication factors and the viral NS1 protein may not be as efficient in single-stranded DNA viruses as expected so far. Furthermore, it has been demonstrated that B19V, similar to parvoviruses infecting animals, has a high rate of evolutionary changes that is more typical of RNA viruses (Ló pez- Bueno et al., 2006; Shackelton et al., 2005; Shackelton & Holmes, 2006) . Since the NS1 gene evolves at a similar rate as the gene for VP2, it was suggested that immune selection is not the primary cause of the high substitution rate in B19V.
In the cases of sequence heterogeneity reported here, a certain similarity of polymorphism was, however, revealed. Thus, we would speculate that, in the situation presented here, a certain kind of mutational or selective mechanism is underlying. Since we only detected the polymorphism in specimens hosting two genotypes, and we and others have not observed a population of different genomes in singly infected individuals, it is tempting to speculate that polymorphism is an effect of double infection. Presuming that infections were acquired sequentially, one might speculate that the incoming infection might exert an effect on the viral genome already resident. Alternatively, given the recently described genetic instability of the virus (Shackelton & Holmes, 2006) and the fact that genotype 2 virus has widely disappeared from circulation but its genome can be frequently detected in tissue from people born before~1960 (Norja et al., 2006) , possibly a more attractive speculation is that the 'new' genotype 1 virus has evolved from the genotype 2 virus under immune pressure raised by infections with genotype 2 virus. In this context, it is noteworthy to mention that in earlier studies in the Aleutian mink disease parvovirus system more than one viral genome sequence was observed in highly virulent isolates (Gottschalck et al., 1991) .
Genotype 2 genome 32.2 revealed a higher genetic divergence from the genotype 2 prototype strains than the other genotype 2 genomes of this study or database sequences, resulting in phylogenetic tree analysis with a separate branch within the cluster of genotype 2 genomes. This might indicate that the degree of genetic diversity among the genotype 2 viruses is similar to that observed among genotypes 3 and 1 viruses (Toan et al., 2006; Parsyan et al., 2007) .
In the study presented here, B19V genotype 3 DNA was detected much less frequently than genotype 1 or 2 DNA. This difference is most likely due to the geographical distribution of genotype 3. Up to now, no genotype 3 virus was detected in Germany and all individuals of this study infected by genotype 3 were from foreign countries. The three singly infected genotype 3 individuals were from Morocco, Turkey (Istanbul) and Egypt (near the Sudanese border), respectively. The individual infected with genotypes 1 and 3 was from the Turkish Aegean coast. Hokynar et al., 2004, qPCR-2) , which might be in line with the age restriction of genotype 2 sequences.
Not surprisingly, the B19V DNA sequences detected in the liver and bone marrow of the same individual were identical. Although the number of specimens investigated was rather small, the results demonstrate that B19V DNA persistence can take place at multiple body sites.
In summary, the results described here show that persistence of two B19V genotypes can occur in the same tissue and that there is evidence for persistence of a repertoire of genomic variants belonging to the same genotype. Finally, genotype 3 appears to be, or was, located in North Africa and in the Near East.
